| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MERUS LABS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MPH HEALTH CARE | 33,400 | -0,30 % | MPH Health Care: First Berlin hebt auf 40 Euro - was die Zahlen tragen | ||
| EYEPOINT | 0,280 | +1,45 % | EyePoint auf UBS-Biopharma-Konferenz: DME-Hoffnungen federn Rückschlag bei feuchter AMD ab | ||
| AMARIN | 10,200 | -0,97 % | Amarin Corporation plc: Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence | Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For Full Year 2026, Company Expects Continued Growth in International Markets, Maintenance of VASCEPA's... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 17,300 | +154,41 % | XETR US81642T2096: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME Waehrung/Currency ISIN BIS/UNTILSELLAS LIFE SCIENCES... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 386,10 | +0,21 % | Madrigal auf der Jefferies-Konferenz: Starker REZDIFFRA-Start und milliardenschwere MASH-Offensive | ||
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 63,00 | -0,79 % | ANI PHARMACEUTICALS INC - 8-K, Current Report | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended September 30, 2026 and Provides Conference Call Information | Conference Call Scheduled for Friday, November 13, 2026 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 12, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company")... ► Artikel lesen | |
| DOGECOIN CASH | - | - | Dogecoin Cash, Inc.: Dogecoin Cash Files Utility Patent For Blockchain Infrastructure Designed To Support Dogecoin Application Usability | Mesquite, NV, June 15, 2026 (GLOBE NEWSWIRE) -- Mesquite, NV - June 15, 2026 - Dogecoin Cash, Inc. (OTC: DOGP) today announced the filing of a U.S. utility patent application with the United States... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,142 | +0,64 % | Theriva Biologics, Inc.: Theriva Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results | - VIRAGE2 enrollment expected to complete in Q4 2026; initial data expected by Q3 2027 -
- Company completes sale of SYN-004 (ribaxamase) and related portfolio of antibiotic-degrading enzymes to... ► Artikel lesen | |
| BMP PHARMA TRADING | 7,600 | 0,00 % | PTA-News: B.M.P. Pharma Trading AG: deutliche Steigerung der Rentabilität im 1. Halbjahr 2026 - Rentabilitätsanstieg EBIT um 52,9% | DJ PTA-News: B.M.P. Pharma Trading AG: deutliche Steigerung der Rentabilität im 1. Halbjahr 2026 - Rentabilitätsanstieg EBIT um 52,9%
Unternehmensmitteilung für den Kapitalmarkt
B.M.P. Pharma... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 5,265 | -5,98 % | Kazia Therapeutics to Host Virtual Event on December 2, 2026: Advancing a New Frontier in Oncology with a First-in-Class Nuclear PD-L1 Protein Degrader | ||
| ALLERGY THERAPEUTICS | 0,008 | -5,88 % | Allergy Therapeutics - Proposed cancellation | ||
| ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | ||
| MEDICURE | 2,340 | -2,50 % | Medicure, Inc.: Medicure Announces Grant of Stock Options | WINNIPEG, MB / ACCESS Newswire / October 1, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen |